COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review

Abdul Mohammed, Neethi Paranji, Po Hung Chen, Bolin Niu

Research output: Contribution to journalReview articlepeer-review


The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelationship with COVID-19 infection in cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, autoimmune hepatitis, and viral hepatitis B. As social distancing and telemedicine gain new footing, we synthesize recommendations from 3 major hepatology societies [American Association for the Study of Liver Disease (AASLD), the European Association for the Study of Liver (EASL), and the Asian Pacific Association for the Study of Liver (APASL)] to present the best approaches for caring for patients with liver diseases as well as those requiring liver transplantation.

Original languageEnglish (US)
Pages (from-to)187-194
Number of pages8
JournalJournal of clinical gastroenterology
Issue number3
StatePublished - Mar 2021


  • COVID-19
  • SARS-CoV-2
  • autoimmune hepatitis
  • cirrhosis
  • hepatitis B
  • hepatocellular carcinoma
  • liver transplantation
  • nonalcoholic liver disease
  • review

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review'. Together they form a unique fingerprint.

Cite this